Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation.

Pane M, Lombardo ME, Alfieri P, D'Amico A, Bianco F, Vasco G, Piccini G, Mallardi M, Romeo DM, Ricotti V, Ferlini A, Gualandi F, Vicari S, Bertini E, Berardinelli A, Mercuri E.

J Pediatr. 2012 Oct;161(4):705-9.e1. doi: 10.1016/j.jpeds.2012.03.020. Epub 2012 May 5.

PMID:
22560791
2.

Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy.

Felisari G, Martinelli Boneschi F, Bardoni A, Sironi M, Comi GP, Robotti M, Turconi AC, Lai M, Corrao G, Bresolin N.

Neurology. 2000 Aug 22;55(4):559-64.

PMID:
10953192
3.

Cognitive and Neurobehavioral Profile in Boys With Duchenne Muscular Dystrophy.

Banihani R, Smile S, Yoon G, Dupuis A, Mosleh M, Snider A, McAdam L.

J Child Neurol. 2015 Oct;30(11):1472-82. doi: 10.1177/0883073815570154. Epub 2015 Feb 6.

PMID:
25660133
4.

Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy.

Taylor PJ, Betts GA, Maroulis S, Gilissen C, Pedersen RL, Mowat DR, Johnston HM, Buckley MF.

PLoS One. 2010 Jan 20;5(1):e8803. doi: 10.1371/journal.pone.0008803.

5.
6.

Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression.

Daoud F, Angeard N, Demerre B, Martie I, Benyaou R, Leturcq F, Cossée M, Deburgrave N, Saillour Y, Tuffery S, Urtizberea A, Toutain A, Echenne B, Frischman M, Mayer M, Desguerre I, Estournet B, Réveillère C, Penisson-Besnier, Cuisset JM, Kaplan JC, Héron D, Rivier F, Chelly J.

Hum Mol Genet. 2009 Oct 15;18(20):3779-94. doi: 10.1093/hmg/ddp320. Epub 2009 Jul 14.

PMID:
19602481
7.
8.

Brain metabolite composition in relation to cognitive function and dystrophin mutations in boys with Duchenne muscular dystrophy.

Kreis R, Wingeier K, Vermathen P, Giger E, Joncourt F, Zwygart K, Kaufmann F, Boesch C, Steinlin M.

NMR Biomed. 2011 Apr;24(3):253-62. doi: 10.1002/nbm.1582. Epub 2010 Dec 7.

PMID:
21404337
9.

Loss of Dp140 regulatory sequences is associated with cognitive impairment in dystrophinopathies.

Bardoni A, Felisari G, Sironi M, Comi G, Lai M, Robotti M, Bresolin N.

Neuromuscul Disord. 2000 Mar;10(3):194-9.

PMID:
10734267
10.

Neuropsychological impairments and the impact of dystrophin mutations on general cognitive functioning of patients with Duchenne muscular dystrophy.

Wingeier K, Giger E, Strozzi S, Kreis R, Joncourt F, Conrad B, Gallati S, Steinlin M.

J Clin Neurosci. 2011 Jan;18(1):90-5. doi: 10.1016/j.jocn.2010.07.118. Epub 2010 Nov 24.

PMID:
21109441
11.

Ocular and neurodevelopmental features of Duchenne muscular dystrophy: a signature of dystrophin function in the central nervous system.

Ricotti V, Jägle H, Theodorou M, Moore AT, Muntoni F, Thompson DA.

Eur J Hum Genet. 2016 Apr;24(4):562-8. doi: 10.1038/ejhg.2015.135. Epub 2015 Jun 17.

12.

Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy?

Moizard MP, Billard C, Toutain A, Berret F, Marmin N, Moraine C.

Am J Med Genet. 1998 Oct 30;80(1):32-41.

PMID:
9800909
13.

[Genotype-phenotype discordance in a Duchenne muscular dystrophy patient due to a novel mutation: insights into the shock absorber function of dystrophin].

López-Hernández LB, van Heusden D, Soriano-Ursúa MA, Figuera-Villanueva L, Vázquez-Cárdenas NA, Canto P, Gómez-Díaz B, Coral-Vázquez RM.

Rev Neurol. 2011 Jun 16;52(12):720-4. Spanish.

14.

[Central nervous system involvements in Duchenne/Becker muscular dystrophy].

Kumagai T, Miura K, Ohki T, Matsumoto A, Miyazaki S, Nakamura M, Ochi N, Takahashi O.

No To Hattatsu. 2001 Nov;33(6):480-6. Japanese.

PMID:
11725514
15.

The prevalence of features of attention deficit hyperactivity disorder in a special school in Ireland.

Buckley S, Hillery J, Guerin S, McEvoy J, Dodd P.

J Intellect Disabil Res. 2008 Feb;52(Pt 2):156-62. doi: 10.1111/j.1365-2788.2007.01017.x.

PMID:
18197954
16.

Severe cognitive impairment in DMD: obvious clinical indication for Dp71 isoform point mutation screening.

Moizard MP, Toutain A, Fournier D, Berret F, Raynaud M, Billard C, Andres C, Moraine C.

Eur J Hum Genet. 2000 Jul;8(7):552-6.

17.

Cognitive and psychological profile of males with Becker muscular dystrophy.

Young HK, Barton BA, Waisbren S, Portales Dale L, Ryan MM, Webster RI, North KN.

J Child Neurol. 2008 Feb;23(2):155-62. Epub 2007 Dec 3.

PMID:
18056690
18.

A different spectrum of DMD gene mutations in local Chinese patients with Duchenne/Becker muscular dystrophy.

Lo IF, Lai KK, Tong TM, Lam ST.

Chin Med J (Engl). 2006 Jul 5;119(13):1079-87.

PMID:
16834926
19.

Sleep and neurobehavioral characteristics of 5- to 7-year-old children with parentally reported symptoms of attention-deficit/hyperactivity disorder.

O'Brien LM, Holbrook CR, Mervis CB, Klaus CJ, Bruner JL, Raffield TJ, Rutherford J, Mehl RC, Wang M, Tuell A, Hume BC, Gozal D.

Pediatrics. 2003 Mar;111(3):554-63.

PMID:
12612236
20.

The usefulness of Conners' Rating Scales-Revised in screening for attention deficit hyperactivity disorder in children with intellectual disabilities and borderline intelligence.

Deb S, Dhaliwal AJ, Roy M.

J Intellect Disabil Res. 2008 Nov;52(11):950-65. doi: 10.1111/j.1365-2788.2007.01035.x. Epub 2008 Jan 2.

PMID:
18179511

Supplemental Content

Support Center